Ptsd medication list
Pro Research Analysisby 
Searched over 200M research papers
Comprehensive List of Medications for PTSD Treatment
Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective serotonin reuptake inhibitors (SSRIs) are the most extensively studied and commonly prescribed medications for post-traumatic stress disorder (PTSD). They are considered the first-line treatment due to their efficacy and relatively favorable side effect profile. The SSRIs sertraline and paroxetine are the only medications currently approved by the U.S. Food and Drug Administration (FDA) specifically for PTSD 124578. Other SSRIs, such as fluoxetine, have also shown effectiveness in treating PTSD symptoms .
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), has shown promising results in initial studies for both short-term and long-term treatment of PTSD. It is often considered when SSRIs are not effective or tolerated 28.
Tricyclic Antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs)
Tricyclic antidepressants (TCAs) like amitriptyline and monoamine oxidase inhibitors (MAOIs) such as phenelzine have been evaluated in smaller studies. While they have shown some efficacy, their use is often limited by their side effect profiles, which include cardiovascular complications and potential for overdose 468.
Atypical Antipsychotics
Atypical antipsychotics, including risperidone and olanzapine, have been studied as both monotherapy and as augmenters to SSRIs in treatment-resistant PTSD cases. These medications can be particularly useful in managing symptoms such as paranoia and severe flashbacks 28.
Adrenergic Agents
Adrenergic agents like prazosin, an alpha-1 antagonist, have shown efficacy in reducing PTSD-related nightmares and improving sleep quality. This makes them a valuable option for patients experiencing significant sleep disturbances 28.
Anticonvulsants
Anticonvulsants such as topiramate, valproic acid, and lamotrigine have been evaluated in open-label studies and small controlled trials. These medications may be particularly useful in patients with comorbid bipolar disorder or those experiencing significant impulsivity and anger .
Benzodiazepines
Despite their common use in clinical practice, benzodiazepines have not shown consistent efficacy in treating PTSD and are generally not recommended due to their potential for dependency and adverse effects on mood 28.
Investigational and Emerging Treatments
Recent research has explored the potential of novel treatments such as ketamine, which has shown promise in early studies for its rapid and sustained reduction of PTSD symptoms. However, more research is needed to establish its efficacy and safety in larger, controlled trials .
Conclusion
The pharmacotherapy of PTSD includes a variety of medications, with SSRIs being the first-line treatment due to their proven efficacy and safety profile. Other medications, such as SNRIs, TCAs, MAOIs, atypical antipsychotics, adrenergic agents, and anticonvulsants, offer additional options, particularly for treatment-resistant cases or specific symptom clusters. Ongoing research into novel treatments like ketamine holds promise for expanding the therapeutic arsenal for PTSD.
Sources and full results
Most relevant research papers on this topic